Trial Profile
A Double Blind, Randomized, Active Controlled, Parallel Design, Comparative PK, Efficacy, Safety and Immunogenicity Study of Bmab-100 and Avastin, both in Combination with XELOX Chemotherapy in Patients with Metastatic Colorectal Cancer - mCRC
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Pharmacokinetics
- Sponsors Biocon
- 15 Feb 2017 New trial record